Dermavant Sciences, a subsidiary of Roivant Sciences, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology. Dermavant leverages the Roivant platform to develop therapies that have the potential to address high unmet medical needs while driving greater efficiency in research and clinical development.
“THE ABILITY TO TRANSFORM LIVES”
Todd Zavodnick, Chief Executive Officer
“A PASSION FOR HELPING PEOPLE”
Philip M Brown, MD, JD, Chief Medical Officer
“FUNDAMENTALLY CHANGING THE LIVES OF PATIENTS”
David Rubenstein, MD, PhD, Chief Scientific Officer